PlainRecalls
FDA Drug Critical Class I Terminated

Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3 blister cards each blister card contains 28-film coated, biconvex tablets, Rx Only, Manufactured by: Cyndea Pharma, S.L., Olvega (Soria), 42110 Spain, Distributed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801 USA, NDC 59746-763-43

Reported: August 7, 2019 Initiated: July 9, 2019 #D-1837-2019

Product Description

Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3 blister cards each blister card contains 28-film coated, biconvex tablets, Rx Only, Manufactured by: Cyndea Pharma, S.L., Olvega (Soria), 42110 Spain, Distributed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801 USA, NDC 59746-763-43

Reason for Recall

Failed dissolution specifications : failed results at the 3-month stability time point.

Details

Units Affected
11,412 cartons/34,236 blister cards/28 tablets each card
Distribution
USA Nationwide
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3 blister cards each blister card contains 28-film coated, biconvex tablets, Rx Only, Manufactured by: Cyndea Pharma, S.L., Olvega (Soria), 42110 Spain, Distributed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801 USA, NDC 59746-763-43. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 11,412 cartons/34,236 blister cards/28 tablets each card.
Why was this product recalled?
Failed dissolution specifications : failed results at the 3-month stability time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 7, 2019. Severity: Critical. Recall number: D-1837-2019.